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Abstract We have tested the putative role of G-protein
L-subunits in insulin exocytosis by transient expression of
LQ-binding proteins targeted to the plasma membrane. The PH
domain of the G-protein-linked receptor kinase 2 fused to the
transmembrane domain of a cell surface receptor and the
K-subunit of the retinal G-protein transducin inhibited stimulated
insulin release from intact and permeabilised HIT-T15 cells. This
effect cannot be imputed to an increase in free GK, as the RGS
protein RGS3 did not reverse this effect. Among the isoforms of
GL examined, GL2 was detected on the plasma membrane by
confocal immunomicroscopy. These observations suggest a role
for G-protein LQ-subunits in insulin exocytosis.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The peptide hormone insulin is stored in large dense-core
vesicles (LDCVs) in pancreatic L-cells. Following transport to
the plasma membrane and ATP-dependent priming of the
vesicle, the hormone is released by exocytosis, that is fusion
between vesicle membranes and the plasma membrane [1,2].
Exocytosis constitutes the ¢nal step in the biosynthetic path-
way from the endoplasmic reticulum to the cell surface [3,4].
This membrane fusion event is triggered in a late step by Ca2
and stimulated in a Ca2-independent manner by GTP or its
more stable analogue GTPQS [5^7]. Several GTPases including
the heterotrimeric GTP-binding proteins are known to regu-
late transport throughout the biosynthetic pathway [8^11].
Heterotrimeric G-proteins are activated by receptors through
a GDP/GTP exchange at the K-subunit [12] and this leads to
dissociation of the trimer into GK and the GLQ dimer. Both
the K-subunit and the LQ-dimer regulate downstream e¡ectors
like ion channels, enzymes or kinases [12,13]. Termination of
G-protein signalling is controlled by the GTPase activity in-
herent in the K-subunit and GTPase activation factors, such
as the recently characterised RGS proteins [14], leading to
reassembly of GK-GDP with GLQ into the inactive trimer GK-
GDPLQ.
Activation of the pertussis toxin (PTX)-sensitive G-proteins
Gi/Go by plasma membrane receptors for several inhibitory
hormones and neurotransmitters, such as galanin, somatosta-
tin and epinephrine, inhibits insulin exocytosis [15]. This reg-
ulation can still be observed in permeabilised cells and there-
fore occurs without the involvement of soluble second
messengers [16^20]. We have previously demonstrated that
the direct inhibition of insulin exocytosis can be mediated
by the K-subunit of Gi1,2,3 or Go2 and that it occurs after
ATP-dependent priming, that is at a late step in exocytosis
[21]. We have now addressed the question whether the LQ-
dimer also plays a role in the regulation of insulin exocytosis.
To this end we transiently expressed proteins endowed with LQ
subunit-binding domains, such as the K-subunit of the retinal
G-protein transducin (TD) [12] or the PH domain of G-pro-
tein-coupled receptor kinase 2 (GRK2PH) [22,23]. As free
GLQ associates with these proteins, GLQ-mediated signalling
is impeded [24^29].
We observed a pronounced e¡ect of LQ subunit-binding
domains on stimulated insulin secretion in intact cells as
well as on insulin exocytosis in permeabilised cells stimulated
by Ca2 or by GTPQS. These observations indicate an impor-
tant role for GLQ-dimers in the direct regulation of insulin
exocytosis.
2. Materials and methods
2.1. Materials
Recombinant pore-forming toxins were kindly provided by Dr U.
Weller (Mainz, Germany). The plasmids pcDNA-TM and pcDNA-
TM-GRK2PH [26] were kindly donated by Dr S. Gutkind (NIH,
Bethesda, MD, USA), pcDNA3-RGS3 [30] and pcDNA-TDK [31]
were generously provided by Dr R. Fisher (University of Iowa,
Iowa City, IA, USA) and Dr R.C. Tsu (Hong Kong University of
Science and Technology, Kowloon, China).
2.2. Cell culture, transient cotransfection, C-peptide release,
immunoblots and confocal immuno£uorescence microscopy
Culture of primary islet cells or HIT T15 cells, transient cotrans-
fections, release experiments from intact or permeabilised cells and
determination of human insulin C-peptide were performed as pub-
lished [21,32,33]. Western blots and confocal immuno£uorescence mi-
croscopy were performed as described previously [32,34,35]. The pri-
mary antibodies were used at the following dilutions: anti-CD8
(Boehringer, Rotkreuz, Switzerland) 1:4000; anti-insulin (Sigma,
Buchs, Switzerland) 1:800; and isoform-speci¢c anti-GL antibodies
(Santa Cruz, Glaser AG, Bale, Switzerland) at 1:300 (immuno£uo-
rescence) or 1:3000 (immunoblots).
2.3. Statistical analysis
Results are presented as mean þ S.D. from experiments performed
independently on at least three di¡erent cell preparations. Statistical
analysis was performed by Student’s two-tailed t-test for unpaired
data (2P).
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3. Results and discussion
3.1. E¡ects of GLQ-binding proteins on insulin secretion from
intact cells
We ¢rst examined the e¡ect of GLQ-binding domains on
insulin release from intact HIT-T15 cells, a clonal pancreatic
L-cell line. Recent reports suggest that heterotrimeric G-pro-
teins in£uence membrane fusion or vesicle transport in the
biosynthetic pathway prior to exocytosis [8^11]. To avoid in-
terference with these earlier transport steps, we employed con-
structs targeted to the plasma membrane. The PH domain of
GRK2 fused to the transmembrane domain of the cell surface
receptor CD8, termed TM-GRK2PH, and TDK, the K-sub-
unit of the retinal G-protein, have been shown to be expressed
at the plasma membrane ([12,26]; see also below). To test the
e¡ect of their transient expression, cells were cotransfect-
ed with a plasmid encoding human preproinsulin (phINS)
and the constructs to be studied. Release of human insulin
C-peptide serves as reporter gene for exocytosis in the ham-
ster insulin-secreting cell line HIT-T15 and permits the
study of hormone release exclusively from cotransfect-
ed cells [21,32,33]. None of the constructs studied here
altered the content (data not shown) or basal release (see
Figs. 1^3) of the reporter gene product thus excluding an
e¡ect on early steps in the biosynthetic pathway prior to exo-
cytosis.
As shown in Fig. 1 (CON), secretion of the reporter gene
product human insulin C-peptide can be induced by KCl-in-
duced membrane depolarisation and subsequent Ca2 in£ux
through voltage-dependent Ca2 channels [1] or by the recep-
tor agonist bombesin through activation of phospholipase C
and liberation of Ca2 from intracellular stores [36]. Expres-
sion of the transmembrane domain of CD8 alone (TM) did
not alter secretion (Fig. 1, TM). However, human insulin C-
peptide release evoked by either KCl or bombesin was largely
reduced by expression of the GLQ-binding PH domain of
GRK2 linked to the transmembrane domain of CD8 (TM-
GRK2PH). In addition, the transient expression of the GLQ-
binding protein TDK produced a comparable e¡ect (see Fig.
1). These results suggest that binding of GLQ and blocking of
its signalling function inhibits insulin secretion.
Binding of GLQ may increase the amount of free active GK
(GK-GTP) and the observed e¡ects might re£ect the action of
GK-GTP. Indeed, we have shown previously that inhibition of
insulin exocytosis can be mediated by the K-subunits of the
PTX-sensitive G-proteins Gi/Go [21]. Although such a mech-
anism seems unlikely [24^29], we tested this assumption di-
rectly. To this end we employed an isoform of the recently
identi¢ed regulators of G-protein signalling, the RGS proteins
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Fig. 1. Transient expression of LQ-binding domains inhibits insulin
secretion from intact HIT-T15 cells. HIT-T15 cells were transiently
cotransfected with a plasmid encoding human preproinsulin
(pHINS) and either pcDNA3 (CON), the transmembrane domain of
the surface receptor CD8 (TM), the PH domain of G-protein-
coupled receptor kinase 2 fused to TM (TM-GRK2PH) or the K-
subunit of the retinal G-protein transducin (TDK). 48 h later cells
were washed and subsequently exposed for 8 min to Krebs-Ringer
bu¡er alone (KRB) or KRB containing 50 mM KCl (KCl) or 10
WM of the receptor agonist bombesin (BBS). The secretion of the
reporter gene human insulin C-peptide was measured by ELISA
and values are expressed as percent of cellular content. N = 8^20 for
each condition from four di¡erent experiments; *2P6 0.01 as com-
pared to corresponding incubation in CON.
Fig. 2. Regulator of G-protein signalling (RGS3) reverts epineph-
rine-induced inhibition of secretion, but not the e¡ect of TM-
GRKPH. HIT-T15 cells were cotransfected with phINS (2.5 Wg/
well) and either pcDNA3 (CON, 1.25 Wg/dish), TM-GRK2PH (TM-
GRK2PH; 1.25 Wg/well), RGS3 (RGS3, 1.25 Wg/well) or RGS3 and
TM-GRK2PH (1.25 Wg of each/well). The total amount of cDNA
was ¢lled up to 5 Wg/well with pcDNA3. 48 h later cells were
washed and subsequently exposed for 8 min to KRB alone (CON),
KRB containing 50 mM KCl (KCl) or containing 50 mM KCl and
10 WM epinephrine (KCl+EPI). Secretion of the reporter gene prod-
uct was determined and values are expressed as in Fig. 1. N = 8 for
each condition from four di¡erent experiments; *2P6 0.01 as com-
pared to corresponding incubation in CON.
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[37]. Similar to the e¡ect of GAP on monomeric G-proteins
[38], RGS proteins interact with GK-subunits and enhance
their GTPase activity thereby driving them into the inactive
GDP-bound state [39]. If the e¡ect of GLQ-binding domains is
mediated by the increased amount of active GK (GK-GTP), it
should be antagonised by coexpression of RGS. One member
of the RGS family, RGS3 [37], has been shown to speci¢cally
antagonise the action of PTX-sensitive G-proteins in intact
cells [30]. To test whether RGS3 interacts also with GKi/
GKo in HIT-T15 cells, we investigated its e¡ect on epine-
phrine-evoked inhibition of insulin secretion, which is known
to be mediated by K2-adrenergic receptors activating the K-
subunit of a PTX-sensitive G-protein [21]. As shown in Fig. 2,
epinephrine decreased KCl-induced secretion by 75%. Note
that RGS3 by itself also slightly reduced stimulated secretion,
an observation that was not unexpected: if RGS3 decreases
the amount of GK-GTP, it will favour the formation of in-
active GKLQ heterotrimers and thereby reduce the amount of
free GLQ. More importantly, expression of RGS3 completely
reversed the e¡ect of epinephrine (Fig. 2) demonstrating its
capacity to antagonise the activation of GKi/GKo. However,
RGS3 expression did not antagonise the inhibition of human
insulin C-peptide release caused by the concomitant expres-
sion of TM-GRK2PH. This clearly demonstrates that the ef-
fect of GLQ-binding domains cannot be explained in terms of
increased amounts of active GK.
3.2. E¡ects of GLQ-binding proteins on exocytosis
The e¡ect of GLQ-binding domains on insulin secretion may
be mediated by a number of mechanisms in intact cells. GLQ
dimers regulate several e¡ectors such as adenylate cyclase,
phospholipase C, Ca2 channels and K channels [12], which
all participate in the expression of the secretory response [1].
To ascertain an e¡ect on exocytosis, the ¢nal step in secretion,
it was therefore necessary to exclude changes in soluble sec-
ond messengers generated by these e¡ectors. Permeabilisation
of cells by the K-toxin from Staphylococcus aureus creates
small pores and permits e¡ective dialysis of soluble cytosolic
second messengers [40] while preserving vigorous exocytosis
[34,41,42]. In such permeabilised cells, exocytosis can be in-
duced either by Ca2 or in a Ca2-independent fashion by
GTP and its stable analogue GTPQS [34,41,42]. As shown in
Fig. 3, GTPQS and Ca2 increased exocytosis of the reporter
gene product human insulin C-peptide 4.5- and 30-fold, re-
spectively. Again the expression of the transmembrane do-
main of CD8 (TM) did not alter the response. Similar to
the observations in intact cells, the Ca2-evoked exocytosis
was abolished by both LQ-binding proteins, that is TM-
GRK2PH and TDK (see Fig. 3). In contrast, GTPQS-evoked
exocytosis was only inhibited by TM-GRK2PH but not by
TDK (see Fig. 3). Indeed, GTPQS added to the permeabilised
cells will bind to transiently expressed TDK and activated
TDK-GTPQS will be unable to scavenge free GLQ-dimers.
To exclude the putative participation of cytosolic proteins,
transiently cotransfected HIT-T15 cells were also permeabi-
lised with streptolysin-O (SL-O). This bacterial haemolysin
creates large pores in the plasma membrane, resulting in the
complete dialysis of the cytosol including macromolecules
[21,32,40]. In SL-O-permeabilised cells TM-GRK2PH again
reduced Ca2-evoked exocytosis by 81 þ 14% as compared
to control transfections (n = 6 for each condition, 2P6 0.01)
and TM alone did not produce any signi¢cant changes. The
observations in permeabilised cells permit several conclusions.
First, the e¡ect of GLQ-binding proteins takes place at the
level of exocytosis and does not depend on the generation
of second messengers or soluble proteins. Second, the ob-
served e¡ects are not due to cellular adaptations during the
expression of these constructs, but are of acute nature. Indeed,
if the observed changes were only of adaptive nature, we
would expect changes also in the content or basal release of
the reporter gene product. More importantly, addition of
GTPQS to the permeabilised cells abolished the e¡ect of tran-
siently expressed TDK clearly demonstrating its acute reversi-
bility.
3.3. Expression of GL and TM-GRK2-PH
We also investigated the endogenous expression of the tar-
gets of LQ-binding domains, namely the G-protein L-subunits,
in insulin-secreting cells. Among the isoforms described [12],
we restricted our analysis to GL1, GL2, GL3 and GL4. Ac-
cording to Western blot analysis (Fig. 4A) these isoforms are
expressed to varying degrees in HIT-T15 cells, except for GL3,
which was undetectable. Immunocytochemistry was per-
formed to study their subcellular localisation. Costaining for
insulin permitted analysis also in primary islet cells, a prepa-
ration always containing non-L-cells. As shown in Fig. 4B,
GL2 was localised at the plasma membrane in HIT-T15 and
primary L-cells. Transient expression of TM-GRK2PH in
HIT-T15 cells led to its expression at the plasma membrane
(Fig. 4B) and colocalisation with endogenous GL2. GL1 and
GL4 were only found at intracellular sites distinct from the
plasma membrane or secretory granules in HIT-15 and pri-
mary L-cells (data not shown).
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Fig. 3. Insulin exocytosis in permeabilised HIT-T15 cells is inhibited
by LQ-binding domains. HIT-T15 cells were transiently cotransfected
as in Fig. 1, permeabilised with K-toxin from S. aureus and subse-
quently exposed to 0.1 WM Ca2, 0.1 WM Ca2 and 100 WM GTPQS
or 10 WM Ca2. The exocytotic release of the reporter gene product
was determined and values are expressed as in Fig. 1. N = 10^13
from ¢ve di¡erent experiments; *2P6 0.05 as compared to control
cotransfections.
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3.4. Conclusions
Our observations demonstrate a pronounced e¡ect of di¡er-
ent LQ-binding domains on insulin exocytosis. The PH domain
of GRK2 binds not only GLQ, but also phospatidylinositol-
4,5-bisphosphate (PtdIns(4,5)P2) [43]. PtdIns(4,5)P2 plays an
important role in vesicle fusion [44,45] and its binding to TM-
GRK2PH might alter the exocytotic response. However, as
exocytosis was also inhibited by TDK, another GLQ-binding
protein, the observed e¡ects cannot be solely explained in
terms of binding of PtdIns(4,5)P2. Therefore, our data indi-
cate a requirement for free GLQ-dimers in the process of exo-
cytosis.
We have not identi¢ed the molecular nature of the GLQ in
question. However, among the four isoforms of GL examined,
only GL2 was found to be expressed at the plasma membrane
whereas GL4 is clearly located to an intracellular organelle.
Moreover, the PH domain of GRK2 binds GL1 and GL2, but
not GL3 [29], excluding the latter isoform as a putative target.
GL2 may thus be involved in exocytosis although we can
currently not exclude a role for other isoforms such as GL5
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Fig. 4. Endogenous GL2 and transiently expressed TM-GRK2PH are located at the plasma membrane. A: Western blot of GL isoforms. Crude
membranes from rat brain (RBM, 20 Wg/lane) or HIT-T15 cells (HIT, 40 Wg/lane) were separated by SDS-PAGE, electroblotted and incubated
with GL-isoform-speci¢c antibodies (anti-L1, -L2, -L3 and -L4). B: Confocal immunocytochemistry. Upper panel: HIT-T15 cells transiently ex-
pressing TM-GRK2PH were ¢xed, permeabilised and double stained with monoclonal anti-CD8 (CD8) antibody recognising the transmembrane
domain of TM-GRK2PH and with a polyclonal anti-GL2 antibody (GL2). Lower panel: Primary islet cells were double-stained with a mono-
clonal anti-insulin antibody (INS) and with a polyclonal anti-GL2 antibody (GL2). Phase contrast images are given on the right.
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[46]. It will obviously be an important future topic to identify
the activator of GL implicated in exocytosis. We have recently
demonstrated that receptor-mediated activation of heterotri-
meric G-proteins can produce not only direct inhibition of
exocytosis [15] mediated by PTX-sensitive GK [21], but also
direct stimulation of exocytosis in endocrine and neuroendo-
crine cells as in the case of the G-protein-coupled receptor
latrophilin/CIRL [47,48]. Receptor-mediated direct stimula-
tion of exocytosis by heterotrimeric G-proteins is therefore
conceivable, although other modes of activation must exist [9].
Interestingly, the LQ-binding domain of GRK2 interfered
with both stimuli for exocytosis, Ca2 and GTPQS. Several
di¡erences between the two stimuli suggest the presence of
two pathways. Whereas both require ATP-dependent priming
of vesicles [6], an early step in exocytosis [2,4], GTPQS-induced
exocytosis proceeds independently of the presence of cytosolic
proteins [42] and the calcium-sensing vesicle protein synapto-
tagmin [32]. Moreover, electrophysiological studies have
clearly indicated the presence of a GTP-dependent step during
Ca2 stimulation of exocytosis [49]. Thus the GTP-dependent
step occurs most likely in parallel to or after the Ca2-depend-
ent step in exocytosis. As the LQ-binding domains a¡ect hor-
mone release evoked by both stimuli, they probably interfere
with a rather late step in exocytosis. It is tempting to speculate
that GLQ may be a mediator of the GTP e¡ect. Future re-
search should provide an answer to this question.
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